Studying the effect of Herbal Drug Entitled Baby Colic Included Melissa Officinalis, Foeniculum Vulgare, Matricaria Chamomilla and Zingiber Officinale on Infant Colic and Comparing it with Gripe Water
Investigating the effect of the combination of chamomile, fennel, ginger and lemon balm in the treatment of infants with infantile colic
Design
This study will be a randomized, double-blind, parallel clinical trial.
Randomization was performed using the permuted block randomization method based on the Rand function in Excel. After entering and completing the informed consent form, participants were placed in two treatment groups of 32 people.
Settings and conduct
Infants with neonatal colic referred to a neonatologist clinic in Kashan will be included in the study based on Rome III criteria. Treatment will be given to individuals for 7 days. The primary outcome of the study is the duration of daily crying. Secondary outcomes include improvement after 3 and 7 days of treatment. Infants who experience a 50% reduction in daily crying compared to the start of treatment will be considered responders to the treatment. Feeding schedule, stool frequency and characteristics, and any adverse events will be observed and recorded.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Every baby aged 3 to 16 weeks who has been diagnosed with infantile colic according to the Rome III criteria.
Exclusion criteria:
Intense or loud crying; Symptoms after 4 months of age; Failure to thrive; Developmental delay; Maternal drug use; Fever or illness; Parental anxiety or maternal depression; Abnormal physical examination; Bloody stool; Vomiting;
Serious complications and illness.
Intervention groups
Baby Colic Syrup: Containing extracts of chamomile, fennel, ginger and lemon balm. Made by Barij Essence Pharmaceutical Company
Gripe water Syrup: Containing extracts of cumin and dill. Made by Dineh Pharmaceutical Company
Main outcome variables
ِDuration of crying; times of crying per day; Stomach ache; Cramps; Mother's opinion about recovery; drug side effects
General information
Reason for update
Acronym
Baby colic
IRCT registration information
IRCT registration number:IRCT20230601058361N1
Registration date:2025-01-20, 1403/11/01
Registration timing:retrospective
Last update:2025-01-20, 1403/11/01
Update count:0
Registration date
2025-01-20, 1403/11/01
Registrant information
Name
Amirhossein Sheida
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 35 3252 5790
Email address
sheidaamirhossein@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-06-10, 1402/03/20
Expected recruitment end date
2024-06-09, 1403/03/20
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Studying the effect of Herbal Drug Entitled Baby Colic Included Melissa Officinalis, Foeniculum Vulgare, Matricaria Chamomilla and Zingiber Officinale on Infant Colic and Comparing it with Gripe Water
Public title
Studying the effect of Herbal Drug Entitled Baby Colic Included Melissa Officinalis, Foeniculum Vulgare, Matricaria Chamomilla and Zingiber Officinale on Infant Colic and Comparing it with Gripe Water
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Every baby aged 3 to 16 weeks who has been diagnosed with infantile colic according to the Rome III criteria.
Exclusion criteria:
Drug use by the mother
Symptoms after 4 months
Failure To Thrive
Drug abuse by the mother
Fever or illness
Parental anxiety or maternal depression
Abnormal physical examination
Bloody stool
Vomiting
Complications and serious illness
Age
From 21 days old to 112 days old
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Data analyser
Sample size
Target sample size:
64
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization is done by blocked method (Permuted block randomization) so that first all 4 blocks containing two codes A and B are prepared (6 blocks) then random blocks are selected by placement using a table of random numbers. These blocks form a sample-sized sequence of A and B codes, each of which is randomly assigned to one of the groups. The list of relevant codes will remain in the formulation section until the completion of the design. With this method, both blinding and randomization will be provided.
Blinding (investigator's opinion)
Double blinded
Blinding description
In order to characterize the characteristics, an independent statistician, blind to the enrolled patients, will design and maintain a computerized two-treatment randomization program with diagnosis blocks of different scales to maintain composition in the allocation of participants between treatment groups. Randomization will be stratified by type of infant feeding (exclusively breastfed or formula fed) and age. At each enrollment, the statistician, who is the only person with access to the randomization program, the drug prescribed will inform the principal investigator and the ITT analysis and analysis, missing data will be imputed using the multiple imputation method. .
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of kashan University of Medical Sciences
Street address
Ravand BLVD.
City
Kashan
Province
Isfehan
Postal code
۸۷۱۵۹۸۱۱۵۱
Approval date
2025-01-13, 1403/10/24
Ethics committee reference number
IR.KAUMS.MEDNT.REC.1402.027
Health conditions studied
1
Description of health condition studied
Infantile colic
ICD-10 code
R10.4
ICD-10 code description
Infantile colic
Primary outcomes
1
Description
Duration of crying
Timepoint
Before treatment, after 3 days of treatment, after 7 days of treatment
Method of measurement
Question from the baby's mother
Secondary outcomes
1
Description
Crying times per day
Timepoint
Before treatment, 3 days after treatment, 7 days after treatment
Method of measurement
Mother's opinion questionnaire
2
Description
Mother's opinion about recovery
Timepoint
3 days after treatment, 7 days after treatment
Method of measurement
Mother's opinion questionnaire
3
Description
Stomach ache
Timepoint
Before treatment, 3 days after treatment, 7 days after treatment
Method of measurement
Mother's opinion questionnaire
4
Description
Cramps
Timepoint
Before treatment, 3 days after treatment, 7 days after treatment
Method of measurement
Mother's opinion questionnaire
Intervention groups
1
Description
Intervention group: Grip water
Category
Treatment - Drugs
2
Description
Intervention group: baby colic
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Shahid beheshti hospital
Full name of responsible person
Mohammadreza sharif
Street address
Ghotb rvandi blv.
City
Kashan
Province
Isfehan
Postal code
8715973447
Phone
+98 31 5554 0026
Email
Beheshtihospital@kaums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Gholam Ali Hamidi
Street address
Ravand Blvd
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5558 9399
Fax
+98 31 5558 9338
Email
hamidi_gh@kaums.ac.ir
Web page address
https://research.kaums.ac.ir/
Grant name
402002
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Barij essence pharmaceutical company
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Industry
Person responsible for general inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Hossein Akbari
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Biostatistics
Street address
Kashan university of medical sciences, Pezeshk Blvd, Ravand Blvd, Kashan
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5558 9399
Fax
+98 31 5558 9338
Email
Akbari1350.h@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Hossein Akbari
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Biostatistics
Street address
Kashan university of medical sciences, Pezeshk Blvd, Ravand Blvd, Kashan
City
Kashan
Province
Isfehan
Postal code
8715973447
Phone
+98 31 5558 9399
Fax
+98 31 5558 9338
Email
Akbari1350.h@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Hossein Akbari
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Biostatistics
Street address
Kashan university of medical sciences, Pezeshk Blvd, Ravand Blvd
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5558 9399
Fax
+98 31 5558 9338
Email
Akbari1350.h@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
Because the drug company does not want to release the data
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
As mentioned, I have no plans to publish the study data
When the data will become available and for how long
After June 23, 2026
To whom data/document is available
Researchers and students who want to use this data to learning statistical analysis
Under which criteria data/document could be used
Learning and research
From where data/document is obtainable
Kashan University of Medical Sciences, Department of Biostatistics and Epidemiology
What processes are involved for a request to access data/document
It is given as a written request to the secretary of the department. The request is sent to the director of the department and after approval it is sent to the researcher.